Limited Cross-Variant Immunity after Infection with the SARS-CoV-2 Omicron Variant Without Vaccination
Rahul K. Suryawanshi(Gladstone Institutes), Mélanie Ott(Gladstone Institutes)
Cited by 35
Related Papers
Rapid assembly of SARS-CoV-2 genomes reveals attenuation of the Omicron BA.1 variant through NSP6
|Nature Communications|2023|69
A single inactivating amino acid change in the SARS-CoV-2 NSP3 Mac1 domain attenuates viral replication in vivo
|PLoS Pathogens|2023|35
The cellular NMD pathway restricts Zika virus infection and is targeted by the viral capsid protein
|bioRxiv (Cold Spring Harbor Laboratory)|2018|7